Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. - Wikidata - awgldk - TriplyDB

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

http://www.wikidata.org/entity/Q33986385

about

Acute hepatitis C: prevention and treatment Viral Sequence Evolution in Acute Hepatitis C Virus Infection Cellular immune selection with hepatitis C virus persistence in humans Acute hepatitis C virus infection: A chronic problem Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design Diagnosis, management, and treatment of hepatitis C: an update A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil.Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection.Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.Humoral immune response in acute hepatitis C virus infection.Acute hepatitis C virus infection in incarcerated injection drug users.Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics.Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection Coinfection with HIV-1 and HCV--a one-two punch.Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance.Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.

P2860

Q22305934-F82B2C58-B41E-4C13-9B35-B7D4EA1CF632 Q27484985-FDABD85B-A4B7-4FC8-9799-186A3AA4A28E Q27485219-CF526EAB-7F6D-4384-B1FC-E7650F515353 Q27485639-F5A3A460-7074-4D6B-8D3F-A79AB241343B Q27488233-D85C91DE-1D3B-4533-ADEB-3AA526CEAABA Q27489594-C57D5517-E015-4B88-A518-E072B4FB32FB Q27490345-9FBA6E24-4D8B-4CD5-8A45-1A5C6DC6253F Q27491349-2219F8C8-9A01-411C-8C4A-8E51F3A383FB Q28476680-A7277EAE-F548-4295-946C-0D8499754C96 Q28477975-4018B2FE-A1BF-440C-8BF4-7D31F219DF9C Q28602408-E9E1E86E-6997-4490-8B8C-4940B6FE6C28 Q29619682-2854ADAE-7658-4AE6-9541-B692B53AE796 Q30383939-2728D378-23AE-4FA5-9A90-8C15FB6AF043 Q30590832-BC8D0F93-9465-457F-8B1A-2182CBBF2C3A Q33631104-E02704C4-6D3B-472E-A776-C04F092934DF Q33650138-B351FAAE-8491-4693-B88F-0E8B15500EB8 Q33707246-8DABE462-38DD-4C72-98B0-2DCC1E2B766D Q33711886-FDB7C967-80AC-4DEF-A8F7-C8DAEC3F1916 Q33791343-B9427FC9-E71A-4CDB-BE84-1664EACF5B2F Q33918411-133C4CAB-CD07-4CA0-8CBF-4CFC460CC70C Q33929089-858E2CA5-DAC9-4248-AF1D-47D7FE73CF95 Q33955998-D1D836A7-F8BC-448E-92A6-E9C58C961E11 Q33989160-25A9CBE2-5803-4F9C-B553-286B7BC750C6 Q33995930-F73A85F6-5469-41B4-8118-E6C37A22E635 Q34259130-6B713C0C-210A-4E5D-ABDC-1C2B380CFFC9 Q34574797-5CA97050-D401-4693-9390-1C06E9CB2E40 Q34764025-F3A70F04-2BFF-49A9-9F63-C0A6D519001D Q34779758-5EE695E4-3975-4198-A343-741A4D38B68D Q34785317-37125E27-5C44-4E11-A596-A08B06C5A23E Q34923937-F449B5CB-3D24-4F26-8BC7-B998A8D8E88B Q35137038-583E9D22-A29E-477F-A46C-347939B33FB6 Q35242585-D54F5EEE-EA0E-4028-A9D5-5A778F1C8A9B Q35249648-C6A80C06-6157-4E9D-A355-BABCCE6FFB70 Q35356381-1C079033-0C48-4F38-9729-B1425D4F6B64 Q35463737-E59CDBB5-CE9A-447C-A9FE-6A0ADF348691 Q35832850-2F65D63F-3DD5-4D94-B9D2-E3FD52E5FE8A Q35973626-4489546E-9311-4E72-A80A-BD7F0889212E Q36067577-654A4677-AC71-46F3-9946-227594490162 Q36148971-D17CA45A-EC47-4054-9FA2-BACDA34543E5 Q36200292-2E419BD0-7293-4209-ADE2-4FC16A57B0FB

P2860

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

http://www.wikidata.org/entity/Q33986385

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@ast

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@en

type

label

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@ast

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@en

prefLabel

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@ast

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@en

P1433

Q33986385-9AC48255-7F64-49D0-87C7-C172AB70B4A7

P1476

Q33986385-822FD263-72DE-4BCA-BB3E-373831EE1F22

P2093

Q33986385-55ED5F9B-A841-4E73-9D5F-AB819DE0FFF5

Q33986385-5896C040-E02D-44D0-A77E-A838480205F8

Q33986385-7197E3C2-E1AE-410D-A41A-33967CC04486

Q33986385-7C4FE384-074D-4428-8B35-E4A75EC4AEDF

Q33986385-9BE2B7FC-CE8F-48FF-AF78-04516F366CE9

Q33986385-A71331AA-C886-4660-9F1D-0F27355E3E3D

Q33986385-AA27D98B-D428-4EF9-B2D9-235DD3C13138

Q33986385-F791B7F5-E68D-48C9-93C1-7E65DB5CE067

P304

Q33986385-C76FED60-CC81-4F73-86DC-B291849E3F75

P31

Q33986385-E58040B8-5C1D-405D-8BEC-8416D0375BE6

P356

Q33986385-13C97191-9F6A-433D-8038-1B65060C186E

P407

Q33986385-C71205FF-D619-4647-B164-CE407D6DC181

P433

Q33986385-F7C12F0E-6B22-4A79-B421-012E49D36ED8

P478

Q33986385-79B06201-36EE-4364-BC0E-73B3738DF7ED

P50

Q33986385-23437417-34D9-4224-B8F6-46D358A72644

Q33986385-4EA86E56-B28B-466F-94C4-09E40DD8E317

Q33986385-E7A50B75-4AE6-4FA3-9984-3407B06211A5

P577

Q33986385-16F0BBB8-3B8F-455D-867B-BF9FE6780DAC

P5875

Q33986385-8B1390EC-31AF-4539-A5BE-8B23783C8407

P698

Q33986385-9A507AE7-9754-452E-9807-EB356D1CA587

P356

P1433

Clinical Infectious Diseases

P1476

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

@en

P2093

Andrea L Cox

http://www.w3.org/2001/XMLSchema#string

Dale M Netski

http://www.w3.org/2001/XMLSchema#string

David Chien

http://www.w3.org/2001/XMLSchema#string

David L Thomas

http://www.w3.org/2001/XMLSchema#string

Steffanie Strathdee

http://www.w3.org/2001/XMLSchema#string

Susan G Sherman

http://www.w3.org/2001/XMLSchema#string

Timothy Mosbruger

http://www.w3.org/2001/XMLSchema#string

Venkatakrishna Shyamala

http://www.w3.org/2001/XMLSchema#string

P304

951-958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/428578

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Danielle C Ompad

P577

2005-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7911926

http://www.w3.org/2001/XMLSchema#string

P698

15824985

http://www.w3.org/2001/XMLSchema#string